Kaouthar Lbiati, MD
Interim Chief Executive Officer
Dr. Kaouthar Lbiati is a biopharma chief executive, board director, policy advisor, and business mentor to the U.S. International Trade Administration’s “Select Global Women in Tech” program. Recognized in Marquis Who’s Who (2024) for her leadership in biotechnology, pharmaceuticals, and global health, she has played pivotal roles across early-stage and multinational life science companies.
She has successfully led cross-functional and multinational teams, secured regulatory approvals, commercialization, and reimbursement for multiple innovative therapies across diverse markets, and attracted multimillion-dollar investments. Throughout her career, she has forged global partnerships and delivered high-impact initiatives that improved patient outcomes and expanded access to cutting-edge technologies.
Her influence extends from operational leadership to the boardroom, where she has overseen strategic direction, guided organizations through crises and major restructurings, and consistently positioned companies for scalability and long-term success.
Dr. Lbiati is also the author of several op-eds on ecosystem development, industrial and technological policy, and global health, published across international outlets.
She earned a Doctor of Medicine (MD) from Mohammed V University in Rabat, a Specialized Executive Master’s from ESSEC Business School in Paris, and a Master of Science in International Policy and Health Economics from the London School of Economics (LSE). She also completed two Executives programs “leading with Finance” at Harvard School of Business and “Corporate Governance” at Columbia Business School.